Clinical Trial Update: Study of the Effect of Intradialytic Vasopressin on Chronic Hypertension in Patients With End Stage Renal Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigated the effect of intradialytic vasopressin on chronic hypertension in patients with end-stage renal disease; results have bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hypertension

Drugs mentioned

• VASOPRESSIN (VASOPRESSIN)

Snippet

Sponsor: Columbia University | Conditions: Hypertension, End Stage Renal Disease | Phase 2 | Status: COMPLETED | Results posted: 2011-04-28